Caffeine consumption linked to dementia risk and drug interactions

Research suggests a complex relationship between caffeine consumption and health, specifically regarding brain function and medication interactions. A perspective article in the journal Dementia indicates that moderate caffeine intake during one's forties may be associated with a reduced risk of developing dementia later in life. This potential protective effect may be influenced by genetic factors, such as CYP1A2 variants which determine caffeine metabolism rates, as well as cultural preparation methods.

However, caffeine can interact significantly with various medical treatments. Certain antibiotics, specifically those in the quinolone family like ciprofloxacin, can slow the body's ability to eliminate caffeine, potentially leading to nervousness, insomnia, or palpitations. Additionally, coffee can reduce the absorption of medications such as levothyroxine, certain antidepressants, and vitamin D supplements. It is recommended to take these medications with water and maintain at least a three-hour separation from caffeine consumption. Furthermore, caffeine can accelerate the elimination of lithium, which is used to treat bipolar disorder, making stable consumption habits essential for patients on such treatments.